BMJ Open Gastroenterology

BMJ Open Gastroenterology
影响因子:
3.3
ISSN:
print: 2054-4774
研究领域:
GASTROENTEROLOGY & HEPATOLOGY
自引率:
3.20%
Gold OA文章占比:
99.54%
原创研究文献占比:
92.96%
SCI收录类型:
Emerging Sources Citation Index (ESCI) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
BMJ Open Gastroenterology is an online-only, peer-reviewed, open access gastroenterology journal, dedicated to publishing high-quality medical research from all disciplines and therapeutic areas of gastroenterology. It is the open access companion journal of Gut and is co-owned by the British Society of Gastroenterology. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around continuous publication, publishing research online as soon as the article is ready.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
5.91.0831.090
学科
排名
百分位
大类:Medicine
小类:Gastroenterology
41 / 167
75%
发文信息
中科院SCI期刊分区
2025年3月20日发布
大类 小类 TOP期刊 综述期刊
3区 医学
4区 胃肠肝病学 GASTROENTEROLOGY & HEPATOLOGY
WOS期刊分区
学科分类
Q2GASTROENTEROLOGY & HEPATOLOGY
历年影响因子
2022年3.1000
2023年3.3000
历年发表
2013年0
2014年9
2015年28
2016年43
2017年45
2018年34
2019年61
2020年83
2021年96
2022年68
投稿信息
出版语言:
English
出版国家(地区):
United Kingdom
审稿时长:
2 weeks
出版商:
BMJ Publishing Group

BMJ Open Gastroenterology - 最新文献

Derivation and validation of lifestyle-based and microbiota-based models for colorectal adenoma risk evaluation and self-prediction.

Pub Date : 2025-04-02 DOI: 10.1136/bmjgast-2024-001597 Yi-Lu Zhou, Jia-Wen Deng, Zhu-Hui Liu, Xin-Yue Ma, Chun-Qi Zhu, Yuan-Hong Xie, Cheng-Bei Zhou, Jing-Yuan Fang

Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy - a retrospective cohort study.

Pub Date : 2025-04-02 DOI: 10.1136/bmjgast-2024-001704 Chino Aneke-Nash, Kay Su Hung, Elizabeth Wall-Wieler, Feibi Zheng, Reem Z Sharaiha

Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.

Pub Date : 2025-03-31 DOI: 10.1136/bmjgast-2024-001615 Siddharth Singh, Jasmine D Nguyen, David I Fudman, Mark E Gerich, Samir A Shah, David Hudesman, Ryan A McConnell, Dana J Lukin, Ann D Flynn, Caroline Hwang, Brandon Sprung, Jill K J Gaidos, Mark C Mattar, David T Rubin, Jana G Hashash, Mark Metwally, Tauseef Ali, Christopher Ma, Frank Hoentjen, Neeraj Narula, Talat Bessissow, Greg Rosenfeld, Jeffrey D McCurdy, Ashwin N Ananthakrishnan, Raymond K Cross, Jorge R Rodriguez Gaytan, Emily-Sophinie Gurrola, Sagar Patel, Corey A Siegel, Gil Y Melmed, S Alandra Weaver, Sydney Power, Guangyong Zou, Vipul Jairath, Jason K Hou
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信